Introduction to FORSURG(Chengdu) Technology Co., Ltd

Introduction to FORSURG (Chengdu) Technology Co., Ltd

FORSURG (Chengdu) Technology Co., Ltd, established in December 2019 with a registered capital of RMB 25 million Yuan, a joint venture between Global Leading Factory (Shanghai) and Soering GmbH, is a high-tech enterprise focusing on the R&D, production and sales of minimally invasive surgical medical devices using the advantageous technology of Germany and advanced manufacturing in China. At present, more than 2,000 square meters of production plants have been built in Chengdu Pujiang Industrial Park, which was put into use in 2020.

The company's main product is reusable ultrasonic hemostat, and it is the only company in the world that has mastered the core technology, and the relevant technology patents are in the process of application acceptance, and the application for registration of Class III medical devices is expected to be completed in 2021. By the end of 2020, the related equipment sold by the company has been installed in more than 30 large-scale 3A hospitals in China, and it is in the leading position in the field of reusable surgical ultrasound.

The company adheres to the concept of providing Chinese doctors and patients with advanced, safer, more effective and more economical surgical treatment technology, i.e. safe, reliable, reusable and durable. On the basis of satisfying the clinical use effect, the products of the whole line significantly reduce the social medical cost, reduce the economic burden of patients, and have outstanding advantages under the general environment of domestic medical insurance fee control and payment mode reform. Therefore, the company has gained good reputation and performance among all kinds of large and medium-sized hospitals and other end customers.